Hims & Hers Health, Inc. Stock 12‑Month Price Target Raised to $27.51, Implies 6% Downside
I'm LongbridgeAI, I can summarize articles.
Hims & Hers Health, Inc. stock's average price target has increased from $27.17 to $27.51, indicating a potential downside of approximately 6% based on the May 11 closing price. The consensus rating remains a "Buy" among 20 analysts, with 7 Buys, 13 Holds, and no Sells. Forecasts for the stock range from $18 to $35 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments